Related Experiment Video
Updated: Oct 13, 2025

Label-Free Imaging of Lipid Storage Dynamics in Caenorhabditis elegans using Stimulated Raman Scattering Microscopy
Published on: May 28, 2021
Ndufa6 regulates adipogenic differentiation via Scd1
Jingwei Zhang, Wei Wang1, Ninghan Feng1,2
1Department of metabolism, Wuxi School of Medicine, Jiangnan University, Wuxi, China.
Abstract:
Obesity and associated complications are becoming a pandemic. Inhibiting adipogenesis is an important intervention for the treatment of obesity. Despite intensive investigations, numerous mechanistic aspects of adipogenesis remain unclear, and many potential therapeutic targets have yet to be discovered. Transcriptomics and lipidomics approaches were used to explore the functional genes regulating adipogenic differentiation and the potential mechanism in OP9 cells and adipose-derived stem cells. In this study, we found that NADH:ubiquinone oxidoreductase subunit A6 (Ndufa6) participates in the regulation of adipogenic differentiation. Furthermore, we show that the effect of Ndufa6 is mediated through stearoyl-CoA desaturase 1 (Scd1) and demonstrate the inhibitory effect of a SCD1 inhibitor on adipogenesis. Our study broadens the understanding of adipogenic differentiation and offers NDUFA6-SCD1 as a potential therapeutic target for the treatment of obesity.
Insights
Researchers identified NADH:ubiquinone oxidoreductase subunit A6 (Ndufa6) as a key regulator in fat cell formation (adipogenesis). Targeting the NDUFA6-SCD1 pathway may offer new obesity treatments.
Area of Science:
- Biochemistry
- Cell Biology
- Metabolic Diseases
Background:
- Obesity is a global pandemic with serious health complications.
- Inhibiting adipogenesis, the process of fat cell formation, is a key strategy for obesity treatment.
- The precise molecular mechanisms governing adipogenesis are not fully understood, leaving potential therapeutic targets undiscovered.
Purpose of the Study:
- To investigate the functional genes regulating adipogenic differentiation.
- To elucidate the molecular mechanisms underlying adipogenesis.
- To identify novel therapeutic targets for obesity treatment.
Main Methods:
- Utilized transcriptomics and lipidomics to analyze gene expression and lipid profiles.
- Employed OP9 cells and adipose-derived stem cells for experimental models.
- Investigated the role of NADH:ubiquinone oxidoreductase subunit A6 (Ndufa6) in adipogenesis.
Main Results:
- Identified Ndufa6 as a significant regulator of adipogenic differentiation.
- Demonstrated that Ndufa6 exerts its effects via stearoyl-CoA desaturase 1 (Scd1).
- Confirmed the inhibitory effect of a SCD1 inhibitor on adipogenesis.
Conclusions:
- Ndufa6 plays a crucial role in regulating adipogenesis.
- The NDUFA6-SCD1 axis represents a novel pathway in adipogenesis.
- The NDUFA6-SCD1 interaction presents a potential therapeutic target for managing obesity.
More Related Videos
08:31Isolation, Culture, and Adipogenic Induction of Neural Crest Original Adipose-Derived Stem Cells from Periaortic Adipose Tissue
Published on: March 2, 2020
09:20An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
Related Concept Videos
Master Transcription Regulators
TGF - β Signaling Pathway